Normalized claim
Time: 40-45% decrease
Estimated 40-45% reduction in CTD authoring time.
Accenture developed an AI-based generative solution to automate creation of Common Technical Documents (CTDs) required for pharmaceutical regulatory submissions to the US FDA. They used Amazon SageMaker JumpStart AI21 models along with AWS Lambda, Amazon S3, Amazon SQS, AWS Step Functions, Amazon Textract, DynamoDB, Amazon Route 53, and AWS Amplify to build an end-to-end document generation and editing workflow. The solution extracts key data from testing reports, generates standardized CTDs, and provides a React web app for document upload, authentication, asynchronous processing, and browser-based document editing. By automating this labor-intensive task, the system reduces CTD authoring time by an estimated 40-45%, improves efficiency, lowers errors, and accelerates drug approval timelines.
Normalized claim
Time: 40-45% decrease
Estimated 40-45% reduction in CTD authoring time.
No explicit deployment-stage evidence found.
Primary read
Showing 3 of 3
The architecture involves a React web app hosted with Route 53 DNS and Amplify authentication, Amazon S3 for document storage, SQS for decoupled job queuing, AWS Lambda functions for processing, AWS Step Functions for orchestration, Amazon Textract for document parsing, DynamoDB for data storage, SageMaker JumpStart for AI model inference and fine-tuning, and a WebSocket connection for real-time updates.
The same organization appears in newer AI deployment evidence.
Measures whether this deployment's public evidence persists — not whether the system is still in production.
AI-generated summary. Verify important details with the linked sources before relying on this case.
Was this useful?
Community
No published comments yet.